FE

Fermi Inc.

FRMI | US

Overview

Corporate Details

ISIN(s):
US3149111086
LEI:
529900TSHBYBCFMYZ228
Country:
United States of America
Address:
N/A
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

No description available.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-01 13:10
Environmental & Social Information
Fermi and MVM EGI Announce Hybrid Cooling MOU
English 13.9 KB
2025-11-25 08:20
Capital/Financing Update
Response to Speculation
English 10.1 KB
2025-11-13 08:25
Report Publication Announcement
Publication of Fermi Inc. Interim Financial Report
English 10.3 KB
2025-11-11 08:25
Report Publication Announcement
Fermi Posts Third Quarter 2025 Shareholder Letter
English 13.6 KB
2025-11-06 08:25
Regulatory Filings
Advance in Aid of Construction Agreement
English 10.3 KB
2025-11-05 08:25
Report Publication Announcement
Notice of Inaugural Earnings Call
English 13.9 KB
2025-11-04 08:30
Environmental & Social Information
State of Texas Preliminary Approval for First 6GW
English 19.6 KB
2025-10-30 08:00
Regulatory Filings
Partnerships Announcement
English 14.9 KB

Automate Your Workflow. Get a real-time feed of all Fermi Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Fermi Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Fermi Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Adaptive Biotechnologies Corp Logo
Maps immune genetics for blood cancer diagnostics and drug discovery partnerships.
United States of America
ADPT
Adeia Inc. Logo
Invents and licenses foundational IP for the media and semiconductor industries.
United States of America
ADEA
Ainos, Inc. Logo
Develops AI-powered 'SmellTech' diagnostics and immune therapies for point-of-care testing.
United States of America
AIMD
Akero Therapeutics, Inc. Logo
A clinical-stage biotech developing therapies for serious metabolic diseases like MASH.
United States of America
AKRO
Aladdin Healthcare Technologies SE Logo
Develops AI for drug discovery and diagnostics targeting age-related diseases.
Germany
NMI
Aligos Therapeutics, Inc. Logo
Clinical-stage biopharma developing novel oral therapies for liver and viral diseases.
United States of America
ALGS
Alpha Tau Medical Ltd. Logo
Developing Alpha DaRT, a precision alpha-radiation therapy designed to destroy solid tumors.
United States of America
DRTS
Alteogen Inc. Logo
Biotech firm developing next-gen ADCs and biobetters with proprietary platform technologies.
South Korea
196170
AlzeCure Pharma Logo
Develops small-molecule drug therapies for Alzheimer's, pain, and cognitive dysfunction.
Sweden
ALZCUR
ANAPTYSBIO, INC Logo
Clinical-stage biotech developing immunology therapies for autoimmune and inflammatory diseases.
United States of America
ANAB

Talk to a Data Expert

Have a question? We'll get back to you promptly.